58:44
Clinical Challenges in Secondary Prevention of CAD
Broadcast Date
Presenter
Beth L. Abramson, MD, MSc, FRCP, FACC and Jean-Francois Tanguay, MD, FRCPC
Therapeutic Area
Cardiovascular
LEARNING OBJECTIVES:
- Manage the transition from dual anti-platelet therapy at 12 months post-index event to long term antithrombotic management
- Recognize the myth of the stable CAD patient by demonstrating the rate of recurrent event and mortality over 10 years
- Define therapeutic options for two typical patient scenarios: 12 months post-PCI and chronic secondary prevention
- Summarize different therapeutic options and targets for secondary prevention
